New Harbor Capital invests in LGM Pharma

On November 20, 2017, New Harbor Capital invested in LGM Pharma, a life science company in Tennessee, United States.

Deal at a glance

AnnouncedNovember 20, 2017 TypeGrowth Capital TargetLGM Pharma Buyer New Harbor Capital SectorLife Science LocationTennessee, United States ValueNot disclosed

Target company

LGM Pharma

Tennessee, United States

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

New Harbor Capital

Company · 1 deal on record

1st transaction in life science
1st transaction in United States

1deals, all time

1in this sector

2017latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026

ArtesRx LLCSame sector and country · Aug 2026

Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired LGM Pharma?New Harbor Capital invested in LGM Pharma on November 20, 2017.

What type of deal was it?It was a growth capital in the life science sector in 2017.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).